The risk allele (G) and genotype (GG) of the CTLA4 polymorphism, rs231775, have also been associated with the presence of persistently elevated TRAb levels after 5 years of ATD [71], suggesting that these patients may require a longer course of ATD or an alternative therapeutic approach. Here, CTLA4 is linked to Jeune syndrome.